about
Prostaglandin D2 inhibits hair growth and is elevated in bald scalp of men with androgenetic alopeciaFemale pattern alopecia: current perspectivesIdentification of skin-expressed genes possibly associated with wool growth regulation of Aohan fine wool sheepEyelash enhancement properties of topical dechloro ethylcloprostenolamide.Bimatoprost in the treatment of eyelash hypotrichosisEpithelium-mesenchyme interactions control the activity of peroxisome proliferator-activated receptor beta/delta during hair follicle development.Clinical utility and differential effects of prostaglandin analogs in the management of raised intraocular pressure and ocular hypertensionHirsutism following the use of bimatoprost eyedrops for glaucomaThe role of bimatoprost eyelash gel in chemotherapy-induced madarosis: an analysis of efficacy and safety.Multi-therapies in androgenetic alopecia: review and clinical experiences.Enhanced eyelashes: prescription and over-the-counter options.Management of hypotrichosis of the eyelashes: Focus on bimatoprostProstaglandin metabolism in human hair follicle.Metal ions released from fixed orthodontic appliance affect hair mineral content.Eyelashes divert airflow to protect the eye.The Effects of Negative Pressure by External Tissue Expansion Device on Epithelial Cell Proliferation, Neo-Vascularization and Hair Growth in a Porcine Model.Hypertrichosis and Hyperpigmentation in the Periocular Area Associated with Travoprost Treatment.The Modulatable Stem Cell Niche: Tissue Interactions during Hair and Feather Follicle Regeneration.Prostaglandin D2 inhibits wound-induced hair follicle neogenesis through the receptor, Gpr44Diphlorethohydroxycarmalol, Isolated from Ishige okamurae, Increases Prostaglandin E2 through the Expression of Cyclooxygenase-1 and -2 in HaCaT Human KeratinocytesHair-Loss Preventing Effect of Grateloupia ellipticaDoes prostaglandin D2 hold the cure to male pattern baldness?A review of the use of latanoprost for glaucoma since its launch.Latanoprost in the treatment of glaucoma.Experimental and early investigational drugs for androgenetic alopecia.Emerging drugs to treat glaucoma: targeting prostaglandin F and E receptors.Brimonidine and brinzolamide for treating glaucoma and ocular hypertension; a safety evaluation.Prostanoid receptors in anagen human hair follicles.A preliminary study of a Peruvian diet using dietary analysis and hair mineral content as indicators.Expression of the prostaglandin F receptor (FP) gene along the mouse genitourinary tract.Distichiasis in a ferret (Mustela putorius furo).Effects of LATISSE (bimatoprost 0.03 per cent topical solution) on the ocular surface.Identification of genes and proteins associated with anagen wool growth.Efficacy of topical latanoprost versus minoxidil and betamethasone valerate on the treatment of alopecia areata.Bimatoprost in Dermatology.
P2860
Q24604475-B0D9F082-DD53-458F-9BF3-014F66344018Q24626432-FA20B4A4-8043-480C-80DB-823C401217C6Q28649470-BAA2ACD6-7BC9-4EFB-B146-8A4FA6629985Q33345427-4B95E293-98C2-4A4F-873D-C4DA97250095Q33819865-653E12A0-C951-47A6-8BDD-23DA11CFAA79Q33860862-615102CC-2B68-4C2E-B199-E30AC60A3CAEQ34043309-856CC46B-A42C-4F2D-9A09-DE824AB4A6D2Q34145067-D51779BC-5449-4CBE-9ED3-6F301D8E3D9AQ34245159-0E08CA5C-CB17-4DB7-9DC4-2C3641D64904Q34534360-E6D4BDA8-A322-4C03-9DA9-09DBFE1AD622Q34565148-CEDF4C3F-A3CE-4048-986B-B2EBD58ABDA7Q34620347-EE9581F0-FB7E-48E4-8812-DE2F4F0B4FB9Q34662829-4768E90D-4374-46EB-9C7C-07FB3BD2B680Q34978627-15BAA5A4-42CB-4624-97AB-E9FE1D92FF0BQ35291604-0678D729-A40D-43FC-9158-58E8D0CE010FQ36003389-855DAF6A-AB5E-49B1-B9EE-45CCC69063F7Q36214307-31369C3E-1BAB-4518-AA52-545C9B6D51F3Q36474075-1433B10D-B394-4E63-9228-DB4DDFBA218AQ36672721-E4E12BC3-2D64-4632-974B-B78660CAEE12Q37145439-3A8FCB3E-59FA-42E5-9E55-5C08F425F695Q37219377-EDBC1FDD-245A-43D9-9A3E-89D842F4A005Q37696767-6704F6A8-95C7-4E6F-854E-CEF7F8CFE691Q37986149-F35B2D48-36E3-4AAB-BC79-88A7F1A7C2FCQ38261310-5327320B-F607-447A-AF6E-C98E6508B02DQ38660822-40A5FADD-B585-4599-8DA6-7BF7A33380B8Q38725839-B5D741E0-1CD4-4D80-A9E5-E11B3CF87009Q39401937-FCB44389-AFFD-4106-94BE-DD21AE7EF1C9Q42521484-7FB4FFA6-6908-41BD-9F79-EA06F3887C1AQ44054048-2C2113AA-7E24-4682-91FD-5A221EA0518BQ44358907-63AACE7C-AB0A-4614-8D6F-089E840E7408Q46806580-1905F056-B322-45E2-816E-FFE7B6FACACCQ50932647-E165387E-A78D-4725-99FE-A131037B5C33Q51526103-04F1A260-8D91-4EF4-A17B-5A2C2C875C76Q53493680-23FA5579-E108-424A-94B3-47F49DB760DEQ55016498-ABADB930-9745-420D-A5A3-1267793F6B4A
P2860
description
2002 nî lūn-bûn
@nan
2002 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Prostaglandin-induced hair growth.
@ast
Prostaglandin-induced hair growth.
@en
type
label
Prostaglandin-induced hair growth.
@ast
Prostaglandin-induced hair growth.
@en
prefLabel
Prostaglandin-induced hair growth.
@ast
Prostaglandin-induced hair growth.
@en
P1476
Prostaglandin-induced hair growth
@en
P2093
Daniel M Albert
P304
P356
10.1016/S0039-6257(02)00307-7
P478
47 Suppl 1
P577
2002-08-01T00:00:00Z